Does VALSARTAN Cause Lung neoplasm malignant? 84 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Lung neoplasm malignant have been filed in association with VALSARTAN (valsartan). This represents 0.4% of all adverse event reports for VALSARTAN.
84
Reports of Lung neoplasm malignant with VALSARTAN
0.4%
of all VALSARTAN reports
24
Deaths
23
Hospitalizations
How Dangerous Is Lung neoplasm malignant From VALSARTAN?
Of the 84 reports, 24 (28.6%) resulted in death, 23 (27.4%) required hospitalization, and 4 (4.8%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which VALSARTAN Alternatives Have Lower Lung neoplasm malignant Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL